Epithelial-to-Mesenchymal Transition Activates PERK–eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress
2014 · Cancer Discovery · 322 citations
https://doi.org/10.1158/2159-8290.cd-13-0945
E
Ethan S. Sokol
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
295
Papers
5.3K
Citations
34
h-index
61
i10-index
Ethan S. Sokol is an academic researcher from Boston Foundation. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations. The author has an h-index of 34, co-authored 251 publications.
ORCID: 0000-0002-2988-0537Papers by this author
worksHomologous Recombination Deficiency: Concepts, Definitions, and Assays
2022 · The Oncologist · 207 citations
https://doi.org/10.1093/oncolo/oyab053
Pan-Cancer Analysis of <i>BRCA1</i> and <i>BRCA2</i> Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
2020 · JCO Precision Oncology · 172 citations
https://doi.org/10.1200/po.19.00345
Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients
2020 · Nature Communications · 141 citations
https://doi.org/10.1038/s41467-020-19402-8
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1
2017 · Nature Communications · 135 citations
https://doi.org/10.1038/s41467-017-01052-y
Growth of human breast tissues from patient cells in 3D hydrogel scaffolds
2016 · Breast Cancer Research · 129 citations
https://doi.org/10.1186/s13058-016-0677-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat